Evidence map›Paper›PMID 38682463›Full record

ArticleBiometrics2024

Topical hidden genome: discovering latent cancer mutational topics using a Bayesian multilevel context-learning approach.

Saptarshi Chakraborty, Zoe Guan, Colin B Begg, Ronglai Shen

Abstract read
In one paragraph

Article in Biometrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Saptarshi ChakrabortyDepartment of Biostatistics, State University of New York at Buffalo, Buffalo, NY 14214, USA.ORCID 0000-0002-3121-9174
Zoe GuanBiostatistics Center, Mass General Research Institute, Boston, MA 02114, USA.ORCID 0000-0002-1015-4666
Colin B BeggDepartment of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0003-3772-1795
Ronglai ShenDepartment of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0001-9694-584X

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Project 3P50CA265826 · NCI · DANA-FARBER CANCER INST · PI David A Barbie · 2022 to 2026
$13.7M
Harnessing Rare Variants for Tumor ClassificationR01CA251339 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI BEGG, COLIN B, SHEN, RONGLAI · 2021 to 2023
$1.2M
Leveraging the Hidden Genome to Recover the Missing Heritability of CancerR21CA270428 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI BEGG, COLIN B, SHEN, RONGLAI · 2023 to 2023
$455k
NCI NIH HHS CA251339NCI NIH HHS P30 CA008748NCI NIH HHS P50 CA265826NCI NIH HHS R01 CA251339NCI NIH HHS R21 CA270428
6 · The paper itself

Abstract

Inferring the cancer-type specificities of ultra-rare, genome-wide somatic mutations is an open problem. Traditional statistical methods cannot handle such data due to their ultra-high dimensionality and extreme data sparsity. To harness information in rare mutations, we have recently proposed a formal multilevel multilogistic "hidden genome" model. Through its hierarchical layers, the model condenses information in ultra-rare mutations through meta-features embodying mutation contexts to characterize cancer types. Consistent, scalable point estimation of the model can incorporate 10s of millions of variants across thousands of tumors and permit impressive prediction and attribution. However, principled statistical inference is infeasible due to the volume, correlation, and noninterpretability of mutation contexts. In this paper, we propose a novel framework that leverages topic models from computational linguistics to effectuate dimension reduction of mutation contexts producing interpretable, decorrelated meta-feature topics. We propose an efficient MCMC algorithm for implementation that permits rigorous full Bayesian inference at a scale that is orders of magnitude beyond the capability of existing out-of-the-box inferential high-dimensional multi-class regression methods and software. Applying our model to the Pan Cancer Analysis of Whole Genomes dataset reveals interesting biological insights including somatic mutational topics associated with UV exposure in skin cancer, aging in colorectal cancer, and strong influence of epigenome organization in liver cancer. Under cross-validation, our model demonstrates highly competitive predictive performance against blackbox methods of random forest and deep learning.

Indexed as

AlgorithmsBayes TheoremMutationNeoplasmsHumansModels, StatisticalSkin Neoplasmscontext learningMarkov chain Monte Carlomultilevel Bayesian modelsrare somatic variantstopic modelwhole genome data

Identifiers

PMID38682463
PMCPMC11056772

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.